Skip to main content

Table 4 CMR findings systemic lupus erythematosus (SLE)

From: Evaluation of myocardial involvement in patients with connective tissue disorders: a multi-parametric cardiovascular magnetic resonance study

 

Controls (n = 20)

Patients (n = 13)

P

LV-EF (%)

66 ± 4

63 ± 7

0.60

LV-EDV (ml)

109 ± 28

111 ± 36

1

LV-ESV (ml)

37 ± 13

43 ± 24

0.82

LV-SV

71 ± 16

67 ± 12

0.55

LV-EDD

45 ± 5

46 ± 4

1

LA (cm2)

20 ± 4

17 ± 3

0.02

IVS (mm)

10 ± 2

9 ± 1

0.35

PA (mm)

24 ± 4

22 ± 3

0.08

LV mass (g)

76 ± 18

85 ± 21

0.41

LGE per patient

-

3 (23 %)

 

 Epicardial

-

1 (8 %)

 

 Intramural

-

2 (15 %)

 

 Transmural

-

1 (8 %)

 

 Subendocardial

-

-

 

% LV mass

-

6.2

 

Native T1 (ms)

962 (947–987)

1002 (976–1015)

0.03

Post contrast T1 (ms)

526 (508–553)

507 (479–539)

0.16

ECV (%)

25 (24–27)

26 (25–29)

0.24

T2 (ms)

49 (48–51)

51 (49–53)

0.02

  1. All values are n or mean ± SD or interquartile ranges
  2. CMR cardiac magnetic resonance, LV left ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EDD end-diastolic diameter, LA left atrium, IVS interventricular septum, PA pulmonary artery, LGE late gadolinium enhancement, ECV extracellular volume